Molecularly-Targeted Therapies in Gynecologic Cancer
Journal Title: Gynecology and Obstetrics Research – Open Journal - Year 2018, Vol 5, Issue 1
Abstract
The development of chemotherapy agents that precisely target specific molecular structures in cancer cells have become a priority in oncology research. In principle, this method halts cancer cell proliferation while allowing normal function of healthy cells. These molecular-based chemotherapy agents target many types of molecules involved in the growth, spread, and survival of malignant cells. Several of these target molecules have been identified in female genital tract malignancies, and multiple agents targeted at those molecules have been developed as a treatment. This review outlines three major types of targeted agents that have clinical relevance in the treatment of gynecologic cancer. The first group of drugs inhibits vascular endothelial growth factor (VEGF), which normally facilitates angiogenesis. The second group inhibits poly (ADP-ribose) polymerase (PARP), a base-excision enzyme that repairs single-strand DNA breaks. The final category is a set of drugs that inhibit programmed-cell death protein 1, an immune checkpoint that normally prevents autoimmunity. Therapeutic benefit has been demonstrated for each of these drug types in gynecologic, and particularly ovarian, cancers. New agents, and applications for these agents have been developing at a rapid pace in each of these categories. Food and Drug Administration (FDA) approval has been accelerated for several of these agents in recent years, suggesting a significant change in the process by which new drugs enter the clinical armamentarium. In short, the development of molecularly-targeted drugs for the treatment of cancer is a promising and rapidly-moving field.
Authors and Affiliations
William Robinson
Keywords
Related Articles
- EP ID EP553861
- DOI 10.17140/GOROJ-5-145
- Views 161
- Downloads 0
A Case Report of Solitary Adrenal Metastasis from Early Stage Endometrial Carcinoma
Although Type I endometrial cancers are generally associated with a good prognosis, specific histopathological features portend worse outcomes. Compared to type II tumours which have increased metastatic potential, this...
Competing Endoscopic Surgeries in the Era of Assisted Reproductive Technologies: Evidence and Practice
Now-a-days the assisted reproductive technologies (ART) are progressing and advancing rapidly. Many reproductive medicine specialists do believe in ART to be the first choice for infertile women regardless of age related...
Use of the Partogram in the Bamenda Health District, North-West Region, Cameroon: A Cross-Sectional Study
Background: The partogram is an effective instrument in the follow-up of labor. It enables timely diagnoses of abnormalities and helps in decision-making. Objectives: This study was carried out to 1) establish and compa...
Case Report of Unusual Stromal Luteinization in High-Grade Papillary Serous Carcinoma of the Ovary
Stromal luteinization has been reported to be associated with benign and malignant epithelial ovarian tumors, predominantly mucinous and often endometrioid ovarian neoplasm. We report here an unusual case of marked ovari...
A Novel Contributor to Endometrial Receptivity: Endometrial Microbiota
In the recent years, our knowledge about human reproductive system has increased with the development of assisted reproductive technologies; however, embryo implantation rate is still around 25-30%.1 Embryo implantation...